NEW YORK (GenomeWeb) — Beckman Coulter Life Sciences announced today that it has acquired privately held liquid handling firm Labcyte.
Based in San Jose, California, Labcyte has developed an acoustic droplet ejection technology called Echo that uses sound energy for the contactless transfer of samples and reagents. Specific terms of the acquisition were not disclosed.
"Labcyte's unique product portfolio complements our existing liquid handling and laboratory automation business," Beckman Coulter Life Sciences President Jonathan Pratt said in a statement. "It provides new opportunities to develop and enhance time-saving solutions for customer workflows."
With the acquisition, Labcyte will be integrated into Indianapolis-based Beckman Coulter Life Sciences, which is a subsidiary of Danaher.